NMDA RECEPTOR ACTIVITY AND ITS MODULATION BY SULFHYDRYL COMPOUNDS: CHEMILUMINESCENCE MEASUREMENTS IN RAT BRAIN CORTICAL SYNAPTOSOMES
Abstract
Objective: We have used chemiluminescence (CL) measurements to investigate the effect of modulatory compounds on N-methyl-D-aspartate (NMDA) receptor activity in rat brain frontal cortex synaptosomes.
Methods: Freshly prepared synaptosomes (protein concentration: 5 mg/mL) were incubated with different modulatory molecules such as Zn++ (1 mM), Cd++ (1 mM), reduced glutathione, (GSH) (1 mM, 10 mM), oxidized glutathione (GSSG) (1 mM, 5 mM), dithiothreitol (DTT) (1 mM, 10 mM) and N- ethylmaleimide (NEM) (1 mM, 10 mM) for 5 minutes at room temperature. After preincubation, 0.1 mM NMDA was added either alone or in the presence of 65 mM KCI. CL measurements were taken with lucigenin as enhancer, at 10 second intervals for 1 minute.
Results: Synaptosomes showed a marked increase in CL upon addition of NMDA both in the presence and absence of KCI. When preincubated with the noncompetitive NMDA receptor antagonist (Zn++) or with the calcium channel blocker(Cd++), CL formation was suppressed. DTT, a strong sulfhydryl group reducing agent, increased the activity of NMDA receptor, whereas NEM, a sulfhydryl group alkylating agent, decreased the NMDA receptor activity. Reduced and oxidized forms of glutathione decreased the receptor activity and were protective under excitotoxicity and depolarization conditions.
Conclusion: Our results demonstrated that
endogenous and exogenous sulfhydryl compounds affect the redox modulatory site and play important roles in the generation of reactive oxygen species after activation of the NMDA receptor.
Key Words: Chemiluminescence; Cortical
synaptosomes; Excitotoxicity; NMDA receptor; Sulfhydryl group modulators
References
- /. Wroblewski JT, Danysz W. Modulation of glutamate receptors: molecular mechanisms and functional implications. Ann Rev Pharmacol Toxicol 1989;29:441-4 74.
- Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. In: Bloom F, ed. neuroscience: from the molecular to the cognitive. Amsterdam: Elsevier Science, 1994:47-51.
- Coyle JT, Pultfarcken P. Oxidative stress, glutamate and the neurodegenerative disorders. Science 1993,262:689-695.
- Upton 5/1, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders, n Engl J Med 1994;330:613-622.
- Meldrum BS. The role of glutamate in epilepsy and other CHS disorders, neurology 1994;44:514-523.
- Scatton B. Pharmacology of the excitatory amino
- acids: novel therapeutic approaches in
- neurodegenerative disorders. In: Racagni G,
Details
Primary Language
English
Subjects
-
Journal Section
-
Publication Date
December 3, 2016
Submission Date
May 4, 2016
Acceptance Date
-
Published in Issue
Year 1999 Volume: 12 Number: 2